Market Research Logo

Monoclonal Antibody Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Monoclonal Antibody Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. For instance, in 2017, the U.S. Food & Drug Administration (FDA) approved Darzalex (daratumumab) in combination with pomalidomide and dexamethasone for the treatment of patients suffering from multiple myeloma, who have received two prior therapies. These factors are expected to support growth of the market over the forecast period.

Market Dynamics

Monoclonal antibody therapeutics market is driven by active research and development of novel drugs and significant number of new drug launches and approval. There are number of monoclonal antibodies in the pipeline, which are expected to receive approval over the forecast period. For instance, manufacturers such as Amgen, Inc., Novartis International AG, Merck & Co., Inc., Eily, Lilly, and Company, and others have several monoclonal antibodies in the pipeline. Moreover, efforts of manufacturers to increase number of indications (oncology) for monoclonal antibodies is further expected to boost the market growth over the forecast period. For instance, in June 2018, the U.S. Food & Drug Administration (FDA), expanded the indication of pembrolizumab (Keytruda) to include recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.

Key features of the study:

  • This report provides in-depth analysis of monoclonal antibody therapeutics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2018–2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global monoclonal antibody therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
  • Key companies covered as a part of this study include Pfizer, Inc., Novartis International AG, Amgen, Inc., Sanofi S.A., Merck & Co., Inc., GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd., AbbVie, Inc., Eily, Lilly, and Company, and Bristol-Myers Squibb Company
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, by technology up-gradation, market expansion, and marketing tactics
  • The global monoclonal antibody therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the monoclonal antibody therapeutics market
Detailed Segmentation:
  • Global Monoclonal Antibody Therapeutics Market, By Source:
  • Human
  • Humanized
  • Chimeric
  • Others
  • Global Monoclonal Antibody Therapeutics Market, By Therapeutic Application:
  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Hematological Disorders
  • Others
  • Global Monoclonal Antibody Therapeutics Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Pharmacies
  • Global Monoclonal Antibody Therapeutics Market, By Geography:
  • North America
  • By Source:
  • Human
  • Humanized
  • Chimeric
  • Others
  • By Therapeutic Application:
  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Hematological Disorders
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Pharmacies
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Source:
  • Human
  • Humanized
  • Chimeric
  • Others
  • By Therapeutic Application:
  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Hematological Disorders
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Pharmacies
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Source:
  • Human
  • Humanized
  • Chimeric
  • Others
  • By Therapeutic Application:
  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Hematological Disorders
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Pharmacies
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Source:
  • Human
  • Humanized
  • Chimeric
  • Others
  • By Therapeutic Application:
  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Hematological Disorders
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Pharmacies
  • By Country:
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East
  • By Source:
  • Human
  • Humanized
  • Chimeric
  • Others
  • By Therapeutic Application:
  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Hematological Disorders
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Pharmacies
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Source:
  • Human
  • Humanized
  • Chimeric
  • Others
  • By Therapeutic Application:
  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Hematological Disorders
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Pharmacies
  • By Country:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Pfizer, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Novartis International AG
  • Amgen, Inc.
  • Sanofi S.A.
  • Merck & Co., Inc.
  • GlaxoSmithKline Plc
  • F. Hoffman-La Roche Ltd.
  • AbbVie, Inc.
  • Eily, Lilly, and Company
  • Bristol-Myers Squibb Company
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Source
Market Snippet, By Therapeutic Application
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Technological Evolution
PEST Analysis
Pipeline Analysis
Porter’s Analysis
4. Global Monoclonal Antibody Therapeutics Market, By Source, 2018–2026 (US$ Mn)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-o-Y Growth Analysis, 2018–2026
Segment Trends
Human
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Humanized
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Chimeric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
5. Global Monoclonal Antibody Therapeutics Market, By Therapeutic Application, 2018–2026 (US$ Mn)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-o-Y Growth Analysis, 2018–2026
Segment Trends
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Autoimmune Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Infectious Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Hematological Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
6. Global Monoclonal Antibody Therapeutics Market, By Distribution Channel, 2018–2026 (US$ Mn)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-o-Y Growth Analysis, 2018–2026
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
Specialty Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
7. Global Monoclonal Antibody Therapeutics Market, By Regions, 2018–2026 (US$ Mn)
Introduction
Market Share Analysis, By Region, 2017 and 2026 (%)
Y-o-Y Growth Analysis, For Regions, 2018–2026
North America
Market Size and Forecast, By Source, 2018–2026 (US$ Mn)
Market Size and Forecast, By Therapeutic Application, 2018–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2018–2026 (US$ Mn)
Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
U.S.
Canada
Europe
Market Size and Forecast, By Source, 2018–2026 (US$ Mn)
Market Size and Forecast, By Therapeutic Application, 2018–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2018–2026 (US$ Mn)
Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Source, 2018–2026 (US$ Mn)
Market Size and Forecast, By Therapeutic Application, 2018–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2018–2026 (US$ Mn)
Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of APAC
Latin America
Market Size and Forecast, By Source, 2018–2026 (US$ Mn)
Market Size and Forecast, By Therapeutic Application, 2018–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2018–2026 (US$ Mn)
Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
Brazil
Mexico
Rest of Latin America
Africa
Market Size and Forecast, By Source, 2018–2026 (US$ Mn)
Market Size and Forecast, By Therapeutic Application, 2018–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2018–2026 (US$ Mn)
Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
Central Africa
South Africa
North Africa
Middle East
Market Size and Forecast, By Source, 2018–2026 (US$ Mn)
Market Size and Forecast, By Therapeutic Application, 2018–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2018–2026 (US$ Mn)
Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
GCC
Israel
Rest of Middle East
8. Competitive Landscape
Company Profiles
Pfizer, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis International AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Amgen, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Sanofi S.A.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Merck & Co., Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline Plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
F. Hoffman-La Roche Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
AbbVie, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Eily, Lilly, and Company
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Bristol-Myers Squibb Company
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 26 market data tables and 37 figures on "Monoclonal Antibody Therapeutics Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report